|
|
Article: Neose Technologies, Inc. and Monsanto Protein Technologies Sign Research Agreement.
- Article from:
- PR Newswire
- Article date:
- November 25, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Neose Technologies, Inc. and Monsanto Protein Technologies, a unit of Monsanto Company , today announced that they have entered into a research agreement to investigate the use of Neose's GlycoAdvance(TM) technology to enhance the glycosylation of therapeutic monoclonal antibodies produced in plants.
Today, the majority of therapeutic monoclonal antibodies are produced by mammalian cell culture. The glycosylation patterns of plant-produced monoclonal antibodies differ significantly from monoclonal antibodies produced by mammalian cell culture. Monoclonal antibodies produced in plants have incomplete glycosylation patterns, resulting in the inability to ...